BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 22047681)

  • 1. Randomized phase III clinical trial of a combined treatment with carnitine + celecoxib ± megestrol acetate for patients with cancer-related anorexia/cachexia syndrome.
    Madeddu C; Dessì M; Panzone F; Serpe R; Antoni G; Cau MC; Montaldo L; Mela Q; Mura M; Astara G; Tanca FM; Macciò A; Mantovani G
    Clin Nutr; 2012 Apr; 31(2):176-82. PubMed ID: 22047681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised phase III clinical trial of 5 different arms of treatment on 332 patients with cancer cachexia.
    Mantovani G
    Eur Rev Med Pharmacol Sci; 2010 Apr; 14(4):292-301. PubMed ID: 20496538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized phase III clinical trial of a combined treatment for cachexia in patients with gynecological cancers: evaluating the impact on metabolic and inflammatory profiles and quality of life.
    Macciò A; Madeddu C; Gramignano G; Mulas C; Floris C; Sanna E; Cau MC; Panzone F; Mantovani G
    Gynecol Oncol; 2012 Mar; 124(3):417-25. PubMed ID: 22198049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized phase III clinical trial of five different arms of treatment for patients with cancer cachexia: interim results.
    Mantovani G; Macciò A; Madeddu C; Gramignano G; Serpe R; Massa E; Dessì M; Tanca FM; Sanna E; Deiana L; Panzone F; Contu P; Floris C
    Nutrition; 2008 Apr; 24(4):305-13. PubMed ID: 18262758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia.
    Mantovani G; Macciò A; Madeddu C; Serpe R; Massa E; Dessì M; Panzone F; Contu P
    Oncologist; 2010; 15(2):200-11. PubMed ID: 20156909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized double-blind clinical trial of combined treatment with megestrol acetate plus celecoxib versus megestrol acetate alone in cachexia-anorexia syndrome induced by GI cancers.
    Kouchaki B; Janbabai G; Alipour A; Ala S; Borhani S; Salehifar E
    Support Care Cancer; 2018 Jul; 26(7):2479-2489. PubMed ID: 29442239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical studies on the treatment of cancer cachexia with megestrol acetate plus thalidomide.
    Wen HS; Li X; Cao YZ; Zhang CC; Yang F; Shi YM; Peng LM
    Chemotherapy; 2012; 58(6):461-7. PubMed ID: 23406994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group.
    ; Strasser F; Luftner D; Possinger K; Ernst G; Ruhstaller T; Meissner W; Ko YD; Schnelle M; Reif M; Cerny T
    J Clin Oncol; 2006 Jul; 24(21):3394-400. PubMed ID: 16849753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia.
    Loprinzi CL; Kugler JW; Sloan JA; Mailliard JA; Krook JE; Wilwerding MB; Rowland KM; Camoriano JK; Novotny PJ; Christensen BJ
    J Clin Oncol; 1999 Oct; 17(10):3299-306. PubMed ID: 10506633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II study with antioxidants, both in the diet and supplemented, pharmaconutritional support, progestagen, and anti-cyclooxygenase-2 showing efficacy and safety in patients with cancer-related anorexia/cachexia and oxidative stress.
    Mantovani G; Macciò A; Madeddu C; Gramignano G; Lusso MR; Serpe R; Massa E; Astara G; Deiana L
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):1030-4. PubMed ID: 16702388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of eicosapentaenoic and docosahexaenoic n-3 fatty acids from fish oil and preferential Cox-2 inhibition on systemic syndromes in patients with advanced lung cancer.
    Cerchietti LC; Navigante AH; Castro MA
    Nutr Cancer; 2007; 59(1):14-20. PubMed ID: 17927497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of megestrol acetate in patients with advanced cancer: a randomized, double-blind, crossover study.
    Bruera E; Ernst S; Hagen N; Spachynski K; Belzile M; Hanson J; Summers N; Brown B; Dulude H; Gallant G
    Cancer Prev Control; 1998 Apr; 2(2):74-8. PubMed ID: 9765767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized trials of megestrol acetate for AIDS-associated anorexia and cachexia.
    Von Roenn JH
    Oncology; 1994 Oct; 51 Suppl 1():19-24. PubMed ID: 7970504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort.
    Jatoi A; Rowland K; Loprinzi CL; Sloan JA; Dakhil SR; MacDonald N; Gagnon B; Novotny PJ; Mailliard JA; Bushey TI; Nair S; Christensen B;
    J Clin Oncol; 2004 Jun; 22(12):2469-76. PubMed ID: 15197210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of megestrol acetate on anorexia, weight loss and cachexia in cancer and AIDS patients (review).
    Strang P
    Anticancer Res; 1997; 17(1B):657-62. PubMed ID: 9066597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia.
    Loprinzi CL; Michalak JC; Schaid DJ; Mailliard JA; Athmann LM; Goldberg RM; Tschetter LK; Hatfield AK; Morton RF
    J Clin Oncol; 1993 Apr; 11(4):762-7. PubMed ID: 8478668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Palliative treatment of cancer anorexia with oral suspension of megestrol acetate.
    Tomíska M; Tomisková M; Salajka F; Adam Z; Vorlícek J
    Neoplasma; 2003; 50(3):227-33. PubMed ID: 12937858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer-related anorexia/cachexia syndrome and oxidative stress: an innovative approach beyond current treatment.
    Mantovani G; Madeddu C; Macciò A; Gramignano G; Lusso MR; Massa E; Astara G; Serpe R
    Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1651-9. PubMed ID: 15466983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study.
    Jatoi A; Windschitl HE; Loprinzi CL; Sloan JA; Dakhil SR; Mailliard JA; Pundaleeka S; Kardinal CG; Fitch TR; Krook JE; Novotny PJ; Christensen B
    J Clin Oncol; 2002 Jan; 20(2):567-73. PubMed ID: 11786587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine activity in cancer-related anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate.
    Mantovani G; Macciò A; Lai P; Massa E; Ghiani M; Santona MC
    Semin Oncol; 1998 Apr; 25(2 Suppl 6):45-52. PubMed ID: 9625383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.